Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Schizophrenia Gene Therapy
Research from University of Tokushima, Institute of Health Bioscience broadens understanding of schizophrenia gene therapy
April 29th, 2008
Investigators publish new data in the report 'TGFBR2 gene expression and genetic association with schizophrenia.' "TGFBR2 gene is a tumor suppressor gene located at chromosome 3p22, and the locus is reported to be linked with schizophrenia susceptibility. According to the previous studies, a reduced incidence of cancer is observed in schizophrenic patients compared with the general population and tumor suppressor genes may be associated with schizophrenia," scientists in Japan report. "We measured the mRNA expression of TGFBR2 gene in the peripheral leukocytes from 19 medication-free schizophrenics and 25 medication-free major depressive patients compared with age-and...
Source: Cancer Weekly (2008-04-29)
|
